• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声参数作为乳腺癌肿瘤分期和侵袭性的生物标志物:与GP73和miR-27a的相关性

Ultrasonic Parameters as Biomarkers for Tumor Staging and Aggressiveness in Breast Cancer: Correlation with GP73 and miR-27a.

作者信息

Tao Zi-Yu, Rong Rong, Zhou Lei-Ping

机构信息

Obstetrics and Gynecology Hospital Fudan University, Shanghai, 200233, People's Republic of China.

Department of Clinical Laboratory, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230000, People's Republic of China.

出版信息

Int J Gen Med. 2025 Jun 21;18:3313-3321. doi: 10.2147/IJGM.S521769. eCollection 2025.

DOI:10.2147/IJGM.S521769
PMID:40575768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12198353/
Abstract

OBJECTIVE

To investigate correlations between CEUS parameters and serum GP73/miR-27a in breast cancer.

METHODS

In the study, 117 highly suspected breast cancer diagnosed and treated in our hospital during March 2022 to April 2024 were included. Meanwhile, pathologic examination was used as the gold standard for diagnosis in this study. The 117 subjects were divided into breast cancer group (69 cases) and non-breast cancer group (48 cases). Both groups underwent contrast-enhanced ultrasound (CEUS), and the parameters of peak intensity (PI), time to peak (TTP), wash-inslope (WIS), gradient (Grad) were recorded. The levels of GP73 and miR-27 in serum of both groups were examined. The relationship between ultrasonography parameters and serum GP73 and miR-27a expression levels was evaluated by correlation analysis.

RESULTS

CEUS parameters (PI, WIS, Grad) in cancer patients were significantly higher than benign group (P<0.05), while TTP was lower. GP73 and miR-27a levels were elevated in cancer patients (P<0.05), with stage III-IV showing higher values than stage I-II (P<0.05). GP73 correlated positively with Grad (r=0.330, P=0.006), while miR-27a correlated with WIS (r=0.311, P=0.009) and Grad (r=0.424, P<0.001). ROC analysis revealed AUCs of 0.771-0.776 for individual parameters and 0.945 for combined markers.

CONCLUSION

CEUS parameters and serum GP73/miR-27a levels correlate with breast cancer severity, demonstrating synergistic diagnostic value (AUC=0.945), supporting their combined use for early detection and progression assessment.

摘要

目的

探讨乳腺癌中超声造影(CEUS)参数与血清GP73/miR-27a之间的相关性。

方法

本研究纳入2022年3月至2024年4月期间在我院诊断并治疗的117例高度疑似乳腺癌患者。同时,本研究采用病理检查作为诊断的金标准。将117例受试者分为乳腺癌组(69例)和非乳腺癌组(48例)。两组均接受超声造影(CEUS)检查,记录峰值强度(PI)、达峰时间(TTP)、流入斜率(WIS)、梯度(Grad)等参数。检测两组血清GP73和miR-27水平。通过相关性分析评估超声参数与血清GP73和miR-27a表达水平之间的关系。

结果

癌症患者的CEUS参数(PI、WIS、Grad)显著高于良性组(P<0.05),而TTP较低。癌症患者的GP73和miR-27a水平升高(P<0.05),III-IV期的值高于I-II期(P<0.05)。GP73与Grad呈正相关(r=0.330,P=0.006),而miR-27a与WIS(r=0.311,P=0.009)和Grad(r=0.424,P<0.001)相关。ROC分析显示,单个参数的AUC为0.771-0.776,联合标志物的AUC为0.945。

结论

CEUS参数和血清GP73/miR-27a水平与乳腺癌严重程度相关,具有协同诊断价值(AUC=0.945),支持将它们联合用于早期检测和病情进展评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a2d/12198353/4d104fab03a6/IJGM-18-3313-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a2d/12198353/e5b094a6c695/IJGM-18-3313-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a2d/12198353/4d104fab03a6/IJGM-18-3313-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a2d/12198353/e5b094a6c695/IJGM-18-3313-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a2d/12198353/4d104fab03a6/IJGM-18-3313-g0002.jpg

相似文献

1
Ultrasonic Parameters as Biomarkers for Tumor Staging and Aggressiveness in Breast Cancer: Correlation with GP73 and miR-27a.超声参数作为乳腺癌肿瘤分期和侵袭性的生物标志物:与GP73和miR-27a的相关性
Int J Gen Med. 2025 Jun 21;18:3313-3321. doi: 10.2147/IJGM.S521769. eCollection 2025.
2
The application of multimodal ultrasound examination in the differential diagnosis of benign and malignant breast lesions of BI-RADS category 4.多模态超声检查在BI-RADS 4类乳腺良恶性病变鉴别诊断中的应用
Front Med (Lausanne). 2025 Jun 9;12:1596100. doi: 10.3389/fmed.2025.1596100. eCollection 2025.
3
A minimally Invasive Biomarker for Sensitive and Accurate Diagnosis of Parkinson's Disease.一种用于帕金森病灵敏且准确诊断的微创生物标志物。
medRxiv. 2024 Jun 30:2024.06.29.24309703. doi: 10.1101/2024.06.29.24309703.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Oral morphine for cancer pain.口服吗啡用于癌症疼痛。
Cochrane Database Syst Rev. 2016 Apr 22;4(4):CD003868. doi: 10.1002/14651858.CD003868.pub4.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.

本文引用的文献

1
Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship.男性乳腺癌:诊断、治疗及生存情况综述
Curr Oncol Rep. 2024 Jan;26(1):34-45. doi: 10.1007/s11912-023-01489-z. Epub 2024 Jan 2.
2
Circular RNAs in breast cancer diagnosis, treatment and prognosis.环状 RNA 在乳腺癌诊断、治疗和预后中的作用。
Oncol Res. 2023 Dec 28;32(2):241-249. doi: 10.32604/or.2023.046582. eCollection 2023.
3
Artificial intelligence in breast cancer: application and future perspectives.人工智能在乳腺癌中的应用及未来展望。
J Cancer Res Clin Oncol. 2023 Nov;149(17):16179-16190. doi: 10.1007/s00432-023-05337-2. Epub 2023 Sep 1.
4
The Emerging Role of the Microbiota in Breast Cancer Progression.肠道菌群在乳腺癌进展中的新兴作用。
Cells. 2023 Jul 27;12(15):1945. doi: 10.3390/cells12151945.
5
Molecular Classification of Breast Cancer.乳腺癌的分子分类。
PET Clin. 2023 Oct;18(4):441-458. doi: 10.1016/j.cpet.2023.04.002. Epub 2023 May 31.
6
Advances in Radiotherapy for Breast Cancer.乳腺癌放射治疗的进展。
Surg Oncol Clin N Am. 2023 Jul;32(3):515-536. doi: 10.1016/j.soc.2023.03.002.
7
Metaplastic Breast Cancer: Current Understanding and Future Directions.化生性乳腺癌:当前认识与未来方向
Clin Breast Cancer. 2023 Dec;23(8):775-783. doi: 10.1016/j.clbc.2023.04.004. Epub 2023 Apr 19.
8
Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0.乳腺癌:从病理生理学到新的治疗方法 2.0。
Int J Mol Sci. 2023 Jan 29;24(3):2542. doi: 10.3390/ijms24032542.
9
Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis.乳腺钼靶密度与乳腺癌风险:系统评价和荟萃分析。
Breast. 2022 Dec;66:62-68. doi: 10.1016/j.breast.2022.09.007. Epub 2022 Sep 26.
10
Breast Cancer Genetics: Diagnostics and Treatment.乳腺癌遗传学:诊断与治疗。
Genes (Basel). 2022 Sep 6;13(9):1593. doi: 10.3390/genes13091593.